
StudyFinder
MT2013-06C : Treatment of graft Failure after HSCT

Status: Recruiting
The objectives of this study are to assess the following: - Incidence of sustained donor engraftment at day 42 post transplant - Incidence of transplant related mortality (TRM) at day 100 - Overall survival at day 100 and 1 year - Acute GVHD after this second transplant at day 100 and 6 months - Chronic GVHD after this second transplant at day 12 and 24 months
Age: Not specified
Healthy Volunteers:
Inclusion Criteria:
• patients with primary or secondary HSCT graft failure
• see link to clinicaltrials.gov for complete Inclusion and Exclusion criteria
Exclusion Criteria:
• uncontrolled infection at the time of transplant
• patients with Fanconi Anemia or other DNA breakage syndromes
Keywords:
Clinics and Surgery Center (CSC), Failure, Hematopoietic Stem Cell Transplantation, HSCT
Contact(s): Timothy Krepski - tkrepsk1@fairview.org
Principal Investigator: Troy Lund
IRB Number: 1404M49341
System ID: 15449
See this study on ClinicalTrials.gov